Zdravka Medarova

Company: TransCode Therapeutics Inc.

Job title: Chief Scientific Officer & Co-Founder

Seminars:

Evaluating Novel Radiopharmaceutical Targeting Agents for Enhanced Specificity & Efficacy 8:30 am

As we see more innovation to improve targeting approaches across radio conjugates, the design and development of these molecules is no easy ride. With the aim to balance the specificity, efficacy and radiation exposure to non-targeted tissues, this workshop will critically analyze current targeting approaches. Hear the latest content and dive into discussions on: •…Read more

day: Workshop A